Skip to content

Study on the Effect and Mechanism of Iodized Oil on Decidualization of Endometrial Stromal Cells Mediated by gp130-induced Cellular Senescence

Investigation of the Effect and Mechanism of Iodized Oil on Decidualization of Endometrial Stromal Cells Based on gp130-mediated Cellular Senescence

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400089530
Enrollment
Unknown
Registered
2024-09-10
Start date
2024-09-12
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis

Interventions

Experimental group: Patients with infertility and endometriosis.:Iodine Contrast Imaging
Positive control group: Endometriosis patients who did not undergo oil-based contrast hysterosalpingography (HSG).:No intervention
Negative control group: Patients undergoing laparoscopic surgery for non-endometriosis-related conditions such as uterine fibroids or ovarian cysts.:No intervention

Sponsors

The First Affiliated Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 39 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria were as follows: 1) Female patients with endometriosis aged between 18 and 39 years old; 2) Having a natural menstrual cycle; 3) Having undergone HSG.

Exclusion criteria

Exclusion criteria: The exclusion criteria were: 1) Female participants with uncontrolled endocrine disorders known to diminish natural pregnancy chances (e.g., the acute phase of systemic lupus erythematosus); 2) Total motile sperm count after sperm wash of less than 3 million sperm per milliliter in the male partner (or a total motile sperm count of <1 million sperm per milliliter when an analysis after sperm wash was not performed); 3) Participants with incomplete data.

Design outcomes

Primary

MeasureTime frame
Glycoprotein 130(pg130);

Secondary

MeasureTime frame
Cell Counting Kit-8(CCK8);SA-ß-gal staining;TNF-alpha; Reactive Oxygen Species(ROS);Tumor Protein 53(p53);Cyclin-Dependent Kinase Inhibitor 1(p21);Cyclin-Dependent Kinase Inhibitor 2A(p16);Lamin B;Prolactin(PRL);Insulin-like Growth Factor Binding Protein 1(IGFBP1);Interleukin-18(IL-18);Interleukin-6(IL-6);

Countries

China

Contacts

Public ContactAiping Qin

The First Affiliated Hospital of Guangxi Medical University

76285695@qq.com+86 139 7710 2456

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026